TY - JOUR
T1 - World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1
T2 - Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
AU - THE WFSBP TASK FORCE ON TREATMENT GUIDELINES FOR SCHIZOPHRENIA
AU - Hasan, Alkomiet
AU - Falkai, Peter
AU - Wobrock, Thomas
AU - Lieberman, Jeffrey
AU - Glenthoj, Birte
AU - Gattaz, Wagner F.
AU - Thibaut, Florence
AU - Möller, Hans Jürgen
AU - Altamura, A. Carlo
AU - Andreasen, Nancy
AU - Barnes, Thomas R.E.
AU - Ceylan, M. Emin
AU - Ollivier, Jorge Ciprian
AU - Crow, Timothy
AU - Danaci, Aysen Esen
AU - David, Anthony
AU - Davidson, Michael
AU - Deakin, Bill
AU - Elkis, Helio
AU - Farde, Lars
AU - Gaebel, Wolfgang
AU - Gallhofer, Bernd
AU - Gerlach, Jes
AU - Hirsch, Steven Richard
AU - Hojaij, Carlos Roberto
AU - Hwang, Michael
AU - Hwo, Hai Gwo
AU - Jablensky, Assen Verniaminov
AU - Jarema, Marek
AU - Kane, John
AU - Kojima, Takuja
AU - Larach, Veronica
AU - Lieberman, Jeffrey
AU - McGorry, Patrick
AU - Meltzer, Herbert
AU - Möller, Hans Jürgen
AU - Mosolov, S.
AU - Moussaoui, Driss
AU - Olié, Jean Pierre
AU - Palha, Antonio Pacheco
AU - Sarandöl, Asli
AU - Sato, Mitsumoto
AU - Sauer, Heinrich
AU - Schooler, Nina
AU - Taneli, Bilgen
AU - von Knorring, Lars
AU - Weinberger, Daniel
AU - Yamawaki, Shigeto
PY - 2012/7/1
Y1 - 2012/7/1
N2 - These updated guidelines are based on a first edition of the World Federation of Societies of Biological Psychiatry Guidelines for Biological Treatment of Schizophrenia published in 2005. For this 2012 revision, all available publications pertaining to the biological treatment of schizophrenia were reviewed systematically to allow for an evidence-based update. These guidelines provide evidence-based practice recommendations that are clinically and scientifically meaningful and these guidelines are intended to be used by all physicians diagnosing and treating people suffering from schizophrenia. Based on the first version of these guidelines, a systematic review of the MEDLINE/PUBMED database and the Cochrane Library, in addition to data extraction from national treatment guidelines, has been performed for this update. The identified literature was evaluated with respect to the strength of evidence for its efficacy and then categorised into six levels of evidence (A-F; Bandelow et al. 2008b, World J Biol Psychiatry 9:242). This first part of the updated guidelines covers the general descriptions of antipsychotics and their side effects, the biological treatment of acute schizophrenia and the management of treatment-resistant schizophrenia.
AB - These updated guidelines are based on a first edition of the World Federation of Societies of Biological Psychiatry Guidelines for Biological Treatment of Schizophrenia published in 2005. For this 2012 revision, all available publications pertaining to the biological treatment of schizophrenia were reviewed systematically to allow for an evidence-based update. These guidelines provide evidence-based practice recommendations that are clinically and scientifically meaningful and these guidelines are intended to be used by all physicians diagnosing and treating people suffering from schizophrenia. Based on the first version of these guidelines, a systematic review of the MEDLINE/PUBMED database and the Cochrane Library, in addition to data extraction from national treatment guidelines, has been performed for this update. The identified literature was evaluated with respect to the strength of evidence for its efficacy and then categorised into six levels of evidence (A-F; Bandelow et al. 2008b, World J Biol Psychiatry 9:242). This first part of the updated guidelines covers the general descriptions of antipsychotics and their side effects, the biological treatment of acute schizophrenia and the management of treatment-resistant schizophrenia.
KW - Schizophrenia
KW - acute phase treatment
KW - antipsychotics
KW - biological treatment
KW - evidence-based guidelines
KW - treatment
KW - treatment resistance
UR - http://www.scopus.com/inward/record.url?scp=84864408922&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84864408922&partnerID=8YFLogxK
U2 - 10.3109/15622975.2012.696143
DO - 10.3109/15622975.2012.696143
M3 - Article
C2 - 22834451
AN - SCOPUS:84864408922
SN - 1562-2975
VL - 13
SP - 318
EP - 378
JO - World Journal of Biological Psychiatry
JF - World Journal of Biological Psychiatry
IS - 5
ER -